CDK6 as a direct target of miR-195 in hepatocellular carcinoma cells has been reported and the 3′UTR of vascular endothelial growth factor (VEGF) has been demonstrated to contain a potential binding site for miR-378 (67,68). This evidence concerns the gene VEGFA and hepatocellular carcinoma.